| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001058910A3 Lipid-based drug delivery systems |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001043775A3 Hydroxide-releasing agents as skin permeation enhancers |
| 02/21/2002 | WO2001042225A3 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 02/21/2002 | WO2001026658A3 Topical nasal treatment using desloratadine |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | US20020022816 Device |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022663 For producing analgesia in a warm blooded animal |
| 02/21/2002 | US20020022646 Method for systhesizing leflunomide |
| 02/21/2002 | US20020022645 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor |
| 02/21/2002 | US20020022642 As nitric oxide synthase (NOS) inhibitors, used in therapy and prophylaxis of central nervous system disorders, inflammatory disorders, septic shock and other disorders |
| 02/21/2002 | US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022625 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | US20020022615 Cyclic oxyguanidine protease inhibitors |
| 02/21/2002 | US20020022610 Compositions and methods for treating bacterial infections |
| 02/21/2002 | US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022236 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 02/21/2002 | US20020022218 Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 |
| 02/21/2002 | US20020022046 Uses for medical devices having a lubricious, nitric oxide-releasing coating |
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/21/2002 | CA2419550A1 Substituted pyrazoles |
| 02/21/2002 | CA2419540A1 Substituted pyrazoles |
| 02/21/2002 | CA2419133A1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/20/2002 | EP1180365A2 Aerosol formulations of peptides and proteins |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | CN1336926A Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336823A Compositions having improved delivery of actives |
| 02/20/2002 | CN1336822A Compositions having improved stability |
| 02/20/2002 | CN1336214A Traditional Chinese medicine for treating chronic bronchitis |
| 02/20/2002 | CN1336175A Compound nose drops and its prepn. |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079259C Nasal cavity paste for preventing influenza |
| 02/20/2002 | CN1079248C Medicine for treating chronic trachitis and bronchitis and its preparing process |
| 02/20/2002 | CN1079241C Traditional Chinese patent drug for curing cough and asthma |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 02/19/2002 | US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 02/19/2002 | US6348497 Prosthetic joints by reducing bone degradation |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348470 Alleviate cough with theobromine |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348342 Compounds |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | CA2217948C Metered dose inhaler for fluticasone propionate |
| 02/19/2002 | CA2204604C Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 02/19/2002 | CA2082568C Amorphous (quinolin-2-ylmethoxy) indoles |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002011755A1 Method |
| 02/14/2002 | WO2002011742A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/14/2002 | WO2002011718A1 IgE PRODUCTION INHIBITORS |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011711A2 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 02/14/2002 | WO2002011676A2 Method of using diketopiperazines and composition containing them |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |